Parkinsonian side effects induced by a monoamine oxidase inhibitor.

Teusink Jp,G. Alexopoulos,Shamoian Ca
DOI: https://doi.org/10.1176/AJP.141.1.118
IF: 17.7
American Journal of Psychiatry
Abstract:A 75-year-old depressed woman treated with the monoamine oxidase inhibitor (MAOI) phenelzine developed a parkinsonian syndrome that remitted after discontinuation of the drug. The authors discuss possible explanations for this unusual phenomenon.
What problem does this paper attempt to address?